ANVISA: MD studies no more required [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2022-07-13 19:03 (143 d 18:17 ago) – Posting: # 23144
Views: 1,223

Hi Shuanghe,

❝ I remember that you had given some talks about BE to ANVISA staff before.


Twice – the last one dealing with the necessity of multiple dose studies.
Haha, now I can write it esp. for you: See this article. If you are short in time, go straight to its Postscript.
Even shorter executive summary (for the guy in the Armani suit): Multiple dose studies are no more required for the ANVISA.
In April 2021 a revision of the guideline was promised for the next summer. If there is one, I failed to find it at the ANVISA’s website, as usual.*

❝ Maybe next time you can suggest why they should not request schedule time point :lol3:


Sure. :-D



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,428 posts in 4,694 threads, 1,598 registered users;
21 visitors (0 registered, 21 guests [including 8 identified bots]).
Forum time: 12:20 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5